Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
7-day hemodynamic response to carvedilol plus isosorbide mononitrate versus carvedilol alone in cirrhotic portal hypertension
ChiCTR-TRC-10001091Phase 4Completed
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Portal Hypertension (PH) comparing Carvedilol with Carvedilol + isosorbide mononitrate (2 arms). Primary endpoint: HVP. Started Oct 2010; status: completed.
02
Drugs
carvedilolisosorbide mononitrate
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on ChiCTR-TRC-10001091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001091.